MED · Medifast Inc
$11.44
-0.04 (-0.35%)
At close · Aug 14
Market Cap
$127.91M
Shares
11.18M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$100,000,000
as of 2022-06-30
· not restated in filings since 2023-11-06
Remaining Authorization
$20,000,000
as of 2022-06-30
· not restated in filings since 2022-08-03
Program Utilization
80.0%
$80,000,000 used of $100,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-02-17 |
| 2024-12-31 | $0 | 10-K, filed 2026-02-17 |
| 2023-12-31 | $3,602,000 | 10-K, filed 2026-02-17 |
| 2022-12-31 | $126,445,000 | 10-K, filed 2025-02-18 |
| 2021-12-31 | $55,999,000 | 10-K, filed 2024-02-20 |
| 2020-12-31 | $5,000,000 | 10-K, filed 2023-02-21 |
| 2019-12-31 | $33,114,000 | 10-K, filed 2022-02-23 |
| 2018-12-31 | $29,995,000 | 10-K, filed 2021-02-26 |
| 2015-12-31 | $10,516,000 | 10-K, filed 2018-03-16 |
| 2014-12-31 | $33,894,000 | 10-K, filed 2017-03-16 |
| 2013-12-31 | $20,081,000 | 10-K, filed 2016-03-15 |
| 2012-12-31 | $2,764,000 | 10-K, filed 2015-03-16 |
| 2011-12-31 | $20,389,000 | 10-K, filed 2014-03-17 |
| 2010-12-31 | $35,000 | 10-K, filed 2013-03-15 |
| 2009-12-31 | $102,000 | 10-K, filed 2012-03-15 |
Key facts
CIK
910329
CUSIP
58470H101
13F (30d)
109 filings
107 filers
Visit website
Investor relations